Minaris Advanced Therapies (formerly Hitachi Chemical Advanced Therapeutics Solutions) is a global cell and gene therapy CDMO with 25+ years of autologous expertise. The company provides end-to-end GMP manufacturing and advanced testing services for gene-edited autologous (CAR-T, TCR-T), allogeneic (NK, HSC, iPSC), non-edited cell therapies, and vaccines. FDA-registered manufacturing site with FEI number.
CAR-T manufacturing, autologous and allogeneic cell therapy, viral vector production, GMP cell therapy manufacturing, vaccine characterization and lot release
4 sites worldwide
No reviews available yet.
No documents available.